With an increasingly promising roster of approved cell therapies still burdened by complex manufacturing, multiple companies ...
June 9 (Reuters) - Qcells, the U.S. solar arm of Korea's Hanwha, has started making solar cells at its Cartersville, Georgia ...
A roundtable discussion reveals how hybrid distributed models could provide a bridge from centralized cell-therapy ...
Solar manufacturer Qcells has started producing solar cells at its vertically integrated manufacturing facility in Cartersville, Georgia.
Cellular Origins, a TTP company, acquired the ACTIA (Autologous Cell Therapy Industrial Automation) Platform IP, developed by Geoff Hodge while CEO of SOTIO Biotech US. The ACTIA Platform complements ...
CAPEX investment for setting up the PERC production is higher in the case of a MLD setup. Image: Fraunhofer ISE A solar cell manufacturing plant can reduce water consumption by up to 79% with existing ...
It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the US approval of three cell therapy products: Iovance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results